UK Prime Minister announces drive to discover new dementia drugs in £100 million campaign

19 June 2014
london-big

The UK Prime Minister David Cameron will today pledge a new drive by the UK to discover new drugs and treatment that could slow down the onset of dementia or even deliver a cure by 2025.

Speaking at a summit of world health and finance leaders in London, Mr Cameron will say immediate action is needed to address a market failure on dementia research and drug development, which had seen global spending on dementia at five times below research on cancer, with only three drugs making it onto the market in the last 15 years. The UK will bring forward specific proposals on patent extensions, earlier access to new drugs for patients, greater research collaboration and facilitating much high-levels of investment, by October this year.

The commitment comes as the new World Dementia Envoy, Dennis Gillings, warns that if global leaders do not incentivize businesses to invest in research and bring in faster, cheaper clinical trials, they will not meet the ambition to find a cure or disease modifying therapy by 2025.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical